References
1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG and
Enriquez-Sarano M. Burden of valvular heart diseases: a population-based
study. Lancet . 2006;368:1005-11.
2. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE,
Kitzman DW and Otto CM. Clinical factors associated with calcific aortic
valve disease. Cardiovascular Health Study. J Am Coll Cardiol .
1997;29:630-4.
3. Roberts WC and Ko JM. Frequency by decades of unicuspid, bicuspid,
and tricuspid aortic valves in adults having isolated aortic valve
replacement for aortic stenosis, with or without associated aortic
regurgitation. Circulation . 2005;111:920-5.
4. Beppu S, Suzuki S, Matsuda H, Ohmori F, Nagata S and Miyatake K.
Rapidity of progression of aortic stenosis in patients with congenital
bicuspid aortic valves. Am J Cardiol . 1993;71:322-7.
5. Nguyen V, Cimadevilla C, Estellat C, Codogno I, Huart V, Benessiano
J, Duval X, Pibarot P, Clavel MA, Enriquez-Sarano M, Vahanian A and
Messika-Zeitoun D. Haemodynamic and anatomic progression of aortic
stenosis. Heart . 2015;101:943-7.
6. Bahler RC, Desser DR, Finkelhor RS, Brener SJ and Youssefi M. Factors
leading to progression of valvular aortic stenosis. Am J Cardiol .
1999;84:1044-8.
7. Rosenhek R, Klaar U, Schemper M, Scholten C, Heger M, Gabriel H,
Binder T, Maurer G and Baumgartner H. Mild and moderate aortic stenosis.
Natural history and risk stratification by echocardiography. Eur
Heart J . 2004;25:199-205.
8. Capoulade R, Chan KL, Yeang C, Mathieu P, Bosse Y, Dumesnil JG, Tam
JW, Teo KK, Mahmut A, Yang X, Witztum JL, Arsenault BJ, Despres JP,
Pibarot P and Tsimikas S. Oxidized Phospholipids, Lipoprotein(a), and
Progression of Calcific Aortic Valve Stenosis. J Am Coll Cardiol .
2015;66:1236-1246.
9. Shen M, Tastet L, Capoulade R, Arsenault M, Bedard E, Clavel MA and
Pibarot P. Effect of bicuspid aortic valve phenotype on progression of
aortic stenosis. Eur Heart J Cardiovasc Imaging . 2020;21:727-734.
10. Ryu DR, Park SJ, Han H, Lee HJ, Chang SA, Choi JO, Lee SC, Park SW
and Oh JK. Progression rate of aortic valve stenosis in korean patients.J Cardiovasc Ultrasound . 2010;18:127-33.
11. Chan KL, Teo K, Dumesnil JG, Ni A, Tam J and Investigators A. Effect
of Lipid lowering with rosuvastatin on progression of aortic stenosis:
results of the aortic stenosis progression observation: measuring
effects of rosuvastatin (ASTRONOMER) trial. Circulation .
2010;121:306-14.
12. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC,
Saunders LD, Beck CA, Feasby TE and Ghali WA. Coding algorithms for
defining comorbidities in ICD-9-CM and ICD-10 administrative data.Med Care . 2005;43:1130-9.
13. Palta S, Pai AM, Gill KS and Pai RG. New insights into the
progression of aortic stenosis: implications for secondary prevention.Circulation . 2000;101:2497-502.
14. Kim D, Chae D, Shim CY, Cho IJ, Hong GR, Park K and Ha JW.
Predicting Disease Progression in Patients with Bicuspid Aortic Stenosis
Using Mathematical Modeling. J Clin Med . 2019;8.
15. Abdelbaky A, Corsini E, Figueroa AL, Subramanian S, Fontanez S,
Emami H, Hoffmann U, Narula J and Tawakol A. Early aortic valve
inflammation precedes calcification: a longitudinal FDG-PET/CT study.Atherosclerosis . 2015;238:165-72.
16. O’Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE and
Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically
early lesion of ’degenerative’ valvular aortic stenosis.Arterioscler Thromb Vasc Biol . 1996;16:523-32.
17. Venardos N, Nadlonek NA, Zhan Q, Weyant MJ, Reece TB, Meng X and
Fullerton DA. Aortic valve calcification is mediated by a differential
response of aortic valve interstitial cells to inflammation. J
Surg Res . 2014;190:1-8.
18. Cote N, Mahmut A, Bosse Y, Couture C, Page S, Trahan S, Boulanger
MC, Fournier D, Pibarot P and Mathieu P. Inflammation is associated with
the remodeling of calcific aortic valve disease. Inflammation .
2013;36:573-81.
19. Tastet L, Capoulade R, Clavel MA, Larose E, Shen M, Dahou A,
Arsenault M, Mathieu P, Bedard E, Dumesnil JG, Tremblay A, Bosse Y,
Despres JP and Pibarot P. Systolic hypertension and progression of
aortic valve calcification in patients with aortic stenosis: results
from the PROGRESSA study. Eur Heart J Cardiovasc Imaging .
2017;18:70-78.
20. Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM and
Pibarot P. Calcific aortic stenosis. Nat Rev Dis Primers .
2016;2:16006.
21. Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probstfield JL,
Bertoni AG, Budoff MJ and O’Brien KD. Features of the metabolic syndrome
and diabetes mellitus as predictors of aortic valve calcification in the
Multi-Ethnic Study of Atherosclerosis. Circulation .
2006;113:2113-9.
22. Acharya A, Hans CP, Koenig SN, Nichols HA, Galindo CL, Garner HR,
Merrill WH, Hinton RB and Garg V. Inhibitory role of Notch1 in calcific
aortic valve disease. PLoS One . 2011;6:e27743.
23. Bach DS, Siao D, Girard SE, Duvernoy C, McCallister BD, Jr. and
Gualano SK. Evaluation of patients with severe symptomatic aortic
stenosis who do not undergo aortic valve replacement: the potential role
of subjectively overestimated operative risk. Circ Cardiovasc Qual
Outcomes . 2009;2:533-9.
24. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P,
Gohlke-Barwolf C, Boersma E, Ravaud P and Vahanian A. Decision-making in
elderly patients with severe aortic stenosis: why are so many denied
surgery? Eur Heart J . 2005;26:2714-20.
25. Davies RR, Kaple RK, Mandapati D, Gallo A, Botta DM, Jr.,
Elefteriades JA and Coady MA. Natural history of ascending aortic
aneurysms in the setting of an unreplaced bicuspid aortic valve.Ann Thorac Surg . 2007;83:1338-44.